Nuveen LLC Makes New $465,000 Investment in InfuSystem Holdings, Inc. $INFU

Key Points

• Nuveen LLC has invested approximately $465,000 in InfuSystem Holdings, acquiring 86,379 shares, which represents about 0.41% of the company.
• Various large investors have shown interest in InfuSystem, with significant stakes and increases in ownership from firms like Connor Clark & Lunn and Minerva Advisors.
• Analyst ratings for InfuSystem are mixed, with several upgrades, including a consensus price target of $12.50, signaling bullish sentiment despite some recent downgrades.

Nuveen LLC bought a new stake in InfuSystem Holdings, Inc. (NYSE:INFU - Free Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 86,379 shares of the company's stock, valued at approximately $465,000. Nuveen LLC owned approximately 0.41% of InfuSystem as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Nuveen Asset Management LLC raised its holdings in InfuSystem by 14.1% in the fourth quarter. Nuveen Asset Management LLC now owns 86,379 shares of the company's stock valued at $730,000 after acquiring an additional 10,647 shares in the last quarter. BNP Paribas Financial Markets raised its holdings in InfuSystem by 67.9% in the fourth quarter. BNP Paribas Financial Markets now owns 6,844 shares of the company's stock valued at $58,000 after acquiring an additional 2,768 shares in the last quarter. Deutsche Bank AG raised its holdings in InfuSystem by 148.3% in the fourth quarter. Deutsche Bank AG now owns 27,671 shares of the company's stock valued at $234,000 after acquiring an additional 16,526 shares in the last quarter. Two Sigma Investments LP raised its holdings in InfuSystem by 40.4% in the fourth quarter. Two Sigma Investments LP now owns 36,252 shares of the company's stock valued at $306,000 after acquiring an additional 10,427 shares in the last quarter. Finally, Northern Trust Corp raised its holdings in InfuSystem by 7.7% in the fourth quarter. Northern Trust Corp now owns 186,741 shares of the company's stock valued at $1,578,000 after acquiring an additional 13,333 shares in the last quarter. Institutional investors and hedge funds own 71.13% of the company's stock.

Insider Transactions at InfuSystem

In other InfuSystem news, Director Scott Shuda sold 5,752 shares of the firm's stock in a transaction on Friday, August 22nd. The shares were sold at an average price of $9.67, for a total transaction of $55,621.84. Following the transaction, the director directly owned 94,000 shares of the company's stock, valued at approximately $908,980. This trade represents a 5.77% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 11.40% of the company's stock.

InfuSystem Stock Down 4.4%

Shares of NYSE INFU traded down $0.47 during mid-day trading on Friday, reaching $10.16. The company had a trading volume of 225,946 shares, compared to its average volume of 177,809. InfuSystem Holdings, Inc. has a 52-week low of $4.61 and a 52-week high of $11.04. The company has a current ratio of 1.98, a quick ratio of 1.59 and a debt-to-equity ratio of 0.50. The stock has a market cap of $207.53 million, a P/E ratio of 169.36 and a beta of 1.82. The firm has a 50 day simple moving average of $7.62 and a two-hundred day simple moving average of $6.41.

Wall Street Analysts Forecast Growth

Several brokerages recently weighed in on INFU. Roth Capital assumed coverage on shares of InfuSystem in a report on Tuesday, July 22nd. They issued a "buy" rating and a $12.00 target price on the stock. Wall Street Zen downgraded shares of InfuSystem from a "strong-buy" rating to a "buy" rating in a research report on Wednesday, May 14th. Three research analysts have rated the stock with a Strong Buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Strong Buy" and a consensus target price of $12.50.

About InfuSystem

InfuSystem Holdings, Inc, through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states.